Published in Obstet Gynecol on February 01, 1989
Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev (2000) 5.53
Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J Biol Chem (1999) 1.72
The nifH gene product is required for the synthesis or stability of the iron-molybdenum cofactor of nitrogenase from Klebsiella pneumoniae. Eur J Biochem (1986) 1.35
Isolation of a compound from Eupatorium adenophorum (Spreng.) [Ageratina adenophora (Spreng.)] causing hepatotoxicity in mice. Nat Toxins (1995) 0.85
Isolation and identification of a compound from avocado (Persea americana) leaves which causes necrosis of the acinar epithelium of the lactating mammary gland and the myocardium. Nat Toxins (1995) 0.83
A field study conducted at Kidston Gold Mine, to evaluate the impact of arsenic and zinc from mine tailing to grazing cattle. Toxicol Lett (2003) 0.81
Specific activation of glucuronide prodrugs by antibody-targeted enzyme conjugates for cancer therapy. Cancer Res (1992) 0.81
Acute phase response in horses: changes in plasma cation concentrations after localised tissue injury. Vet Rec (1989) 0.80
The magical and medicinal usage of Stangeria eriopus in South Africa. J Ethnopharmacol (1994) 0.80
Copper salicylate and copper phenylbutazone as topically applied anti-inflammatory agents in the rat and horse. J Vet Pharmacol Ther (1990) 0.79
Exercise-induced connective tissue turnover and lipid peroxidation in horses. Br Vet J (1994) 0.79
Assessment of copper and zinc status of farm horses and training thoroughbreds in south-east Queensland. Aust Vet J (1988) 0.79
Unique toxic peptides isolated from sawfly larvae in three continents. Toxicon (1999) 0.79
Porphyrins as early biomarkers for arsenic exposure in animals and humans. Cell Mol Biol (Noisy-le-grand) (2002) 0.79
The elimination of injected superoxide dismutase from synovial fluid of the horse. Aust Vet J (1989) 0.78
Some effects of chronic mercuric chloride intoxication on renal function in a horse. Vet Hum Toxicol (1982) 0.77
Concentration of ptaquiloside, a major carcinogen in bracken fern (Pteridium spp.), from eastern Australia and from a cultivated worldwide collection held in Sydney, Australia. Nat Toxins (1994) 0.77
Stress response to chronic inflammation in the horse. Equine Vet J (1997) 0.77
Vasa praevia--antepartum haemorrhage with sinusoidal fetal heart pattern. Aust N Z J Obstet Gynaecol (1987) 0.76
Effect of palosein (superoxide dismutase) and catalase upon oxygen derived free radical induced degradation of equine synovial fluid. Equine Vet J (1990) 0.75
Assessment of histamine, bradykinin, prostaglandins E1 and E2 and carrageenin as vascular permeability agents in the horse. J Vet Pharmacol Ther (1991) 0.75
A suspected case of acute copper toxicity in a horse. Aust Vet J (1989) 0.75
Kinetics, dose response, tachyphylaxis and cross-tachyphylaxis of vascular leakage induced by endotoxin, zymosan-activated plasma and platelet-activating factor in the horse. J Vet Pharmacol Ther (1995) 0.75
Environmental poisoning: presentation and management. Ther Drug Monit (1998) 0.75
A nonsurgical method of drainage of pyometra. Aust N Z J Obstet Gynaecol (1988) 0.75
The effect of the acute-phase response on in vitro drug metabolism and plasma protein binding in the horse. Vet Res Commun (1997) 0.75
Free radical oxidation products in plasma and synovial fluid of horses with synovial inflammation. Aust Vet J (1993) 0.75
Disposition and urinary excretion of phenylbutazone in normal and febrile greyhounds. Res Vet Sci (1995) 0.75
Anti-inflammatory drugs inhibit degradation of equine synovial fluid induced by free radicals. Aust Vet J (1991) 0.75
Monthly variation in the plasma copper and zinc concentration of pregnant and non-pregnant mares. Aust Vet J (1988) 0.75
Prediction in road safety studies: an empirical inquiry. Accid Anal Prev (1991) 0.75
The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses. J Vet Pharmacol Ther (1996) 0.75
Superoxide production by stimulated equine polymorphonuclear leukocytes--inhibition by anti-inflammatory drugs. J Vet Pharmacol Ther (1990) 0.75
Kinetics of endotoxin, complement and platelet-activating factor (PAF) induced vascular permeability in greyhounds. J Vet Pharmacol Ther (1994) 0.75
Isolation and characterisation of urushiol components from the Australian native cashew (Semecarpus australiensis). Nat Toxins (1997) 0.75
Effects of inflammation-associated acute-phase response on hepatic and renal indices in the horse. Aust Vet J (1998) 0.75
Vascular leakage induced by histamine, bradykinin, serotonin and prostaglandin E2 in greyhounds. Aust Vet J (1993) 0.75
Chronic phenylmercuric acetate toxicity in a horse. Vet Hum Toxicol (1979) 0.75
Phenylbutazone in racing greyhounds: plasma and urinary residues 24 and 48 hours after a single intravenous administration. Aust Vet J (1995) 0.75